SJS Investment Consulting Inc.

Position in NVS — Novartis AG

CIK 1894302 SYLVANIA, OH

Position in NVS

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$288,207

+$29,755 QoQ

Shares Held

1,839

+8.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,151

of 1,603 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SJS Investment Consulting Inc. holds $25,886,295 across 14 Drug Manufacturers - General names. NVS ranks #4 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	19,153	$22,972,684
2	JNJ	Johnson & Johnson	4,507	$1,144,642
3	ABBV	AbbVie Inc.	1,943	$488,936
4	NVS	Novartis AG This page	1,839	$288,207
5	MRK	Merck & Co., Inc.	1,992	$255,972
6	AMGN	Amgen Inc	657	$237,912
7	BMY	Bristol Myers Squibb Co	2,963	$170,728
8	PFE	Pfizer Inc	5,482	$132,005

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$288,207	1,839	+8.7%	Shares	Sole	2026-07-22
2026-03-31	$258,452	1,692	-0.6%	Shares	Sole	2026-04-23
2025-12-31	$234,792	1,703	+32.2%	Shares	Sole	2026-01-21
2025-09-30	$165,173	1,288	+1188.0%	Shares	Sole	2025-10-21
2025-03-31	$11,148	100	0.0%	Shares	Sole	2025-04-15
2024-12-31	$9,731	100	0.0%	Shares	Sole	2025-01-21
2024-09-30	$11,502	100	0.0%	Shares	Sole	2024-10-16
2024-06-30	$10,646	100	0.0%	Shares	Sole	2024-07-16
2024-03-31	$9,673	100	0.0%	Shares	Sole	2024-04-18
2023-12-31	$10,097	100	-37.5%	Shares	Sole	2024-01-16
2022-03-31	$14,040	160	0.0%	Shares	Sole	2022-05-05
2021-12-31	$13,995	160	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.